By the 1960s, Pfizer were at their “most diversified point in [its] history” – in its own words, its interests “stretched from pills to perfume, and petrochemicals to pet products”.

Pfizer must pay $59,746,277 million to resolve allegations ... The anti‑kickback statute prohibits offering or paying anything of value to induce the referral of items or services covered by Medicare, ...

Then, this is the segment with the strongest focus in Pfizer's pipeline. If we take a look at the top 10 products in 2023 ... at potential peak sales of the most important names recently launched ...

Other relevant products are Prevnar 13 ... the stock might be too cheap to ignore. Pfizer does not rank on our latest list of the 31 Most Popular Stocks Among Hedge Funds. As per our database ...

Notable medicines subject to price increases include Pfizer’s COVID-19 drug Paxlovid ... which remains the most popular month for the move. Aside from widespread criticism of steep price ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

Sales of PFE’s COVID Products Declining ... in 2025 and beyond. Pfizer expects 2025 to 2030 revenue CAGR to be approximately 6%. Pfizer is one of the largest and most successful drugmakers ...

There are shareholders who have invested in the company, there are the patients who use Pfizer's products, and there's the global community holding it accountable. And there's also the 90,000 ...

Additionally, the company is counting on revenues from products already launched and others in the pipeline. This is where the gap lies between Pfizer’s outlook and market expectations.

To ensure equitable distribution of the affected drugs and availability to those who most need them, Pfizer has strictly allocated the inventory of many products, the FDA said. "These allocation ...